|
The
net loss and the weighted average number of shares used in computing basic and diluted net loss per share for the period of nine month
ended September 30, 2021 and 2020, is as follows:
SCHEDULE
OF WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES
| |
|
2021 |
|
|
2020 |
|
| |
|
Nine month period ended
September
30,
|
|
| |
|
2021 |
|
|
2020 |
|
| |
|
Unaudited |
|
|
Unaudited |
|
| Numerator: |
|
|
|
|
|
|
|
|
| Net loss attributable to common shareholders |
|
$ |
24,547 |
|
|
$ |
25,258 |
|
Revaluation of liability related to warrants to purchase shares of common
Stock |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Net loss attributable to common shareholders |
|
$ |
24,547 |
|
|
$ |
25,258 |
|
| |
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
|
|
|
| Shares of common stock used in computing basic net loss per share |
|
|
637,916,356 |
|
|
|
210,806,186 |
|
| Incremental shares from assumed exercise of warrants to purchase shares of common stock |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Shares of common stock used in computing diluted net loss per share |
|
|
637,916,356 |
|
|
|
210,806,186 |
|
| |
|
|
|
|
|
|
|
|
| Net loss per share of common stock, basic and diluted |
|
$ |
0.04 |
|
|
$ |
0.12 |
|
|